Australian Statistics on Medicines 2010
Table 1 - Genito Urinary System And Sex Hormones
2010 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
GENITO URINARY SYSTEM AND SEX HORMONES |
|||||||
G01AA10 |
CLINDAMYCIN |
||||||
A |
15081 |
Vaginal cream 2% 40gm |
0.10 |
GM |
18,859 |
— |
|
G01AA01 |
NYSTATIN |
||||||
P |
4013F |
Vaginal cream 100,000 units per dose, 15 doses, 75g |
100.00 |
TE |
5,566 |
76,680 |
|
ORGANIC ACIDS |
|||||||
G01AD02 |
RICINOLEIC ACID, ACETIC ACID and HYDROXYQUINOLINE SULPHATE |
||||||
P |
4434J |
Vaginal jelly 7mg-9.4mg-250ug per g |
— |
— |
155 |
5,149 |
|
IMIDAZOLE DERIVATIVES |
|||||||
G01AF02 |
CLOTRIMAZOLE |
||||||
A |
15913 |
Pessary 500mg |
0.10 |
GM |
1,492 |
— |
|
A |
19067 |
Vaginal cream 50mg per 5g (1%) 35g |
0.10 |
GM |
157 |
— |
|
A |
20605 |
Pessaries 100mg 6 |
0.10 |
GM |
4,366 |
— |
|
A |
20606 |
Pessary 500mg |
0.10 |
GM |
1,887 |
— |
|
A |
20607 |
Vaginal cream 50mg per 5g (1%) 35g |
0.10 |
GM |
9,646 |
— |
|
A |
20608 |
Vaginal cream 100mg per 5g (2%) 20g |
0.10 |
GM |
6,978 |
— |
|
P |
4016J |
Vaginal cream 50mg per 5g (1%) 35g |
0.10 |
GM |
407 |
6,166 |
|
P |
4017K |
Vaginal cream 100mg per 5g (2%) 20g |
0.10 |
GM |
294 |
4,507 |
|
G01AF20 |
CLOTRIMAZOLE and FLUCONAZOLE |
||||||
A |
20144 |
Vaginal Cream 1% 10g and capsule 150mg 1 |
— |
— |
2,275 |
— |
|
G01AF05 |
ECONAZOLE NITRATE |
||||||
A |
12661 |
Foam-sol 1%10g 3 |
0.10 |
GM |
1,250 |
— |
2010 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
GENITO URINARY SYSTEM AND SEX HORMONES |
|||||||
G02BA03 |
LEVONORGESTREL |
||||||
P |
8633J |
Intrauterine drug 52mg releasing 20ug per 24 hours |
— |
— |
80,310 |
19,722,601 |
|
G02BA02 |
POLYETHYLENE COPPER |
||||||
A |
13296 |
Intrauterine device 1 |
— |
— |
606 |
— |
|
OTHER GYNAECOLOGICALS |
|||||||
PROLACTIN INHIBITORS |
|||||||
G02CB01 |
BROMOCRIPTINE MESYLATE |
||||||
P |
1444B |
Tablet 2.5mg |
5.00 |
MG |
3,724 |
74,113 |
|
G02CB03 |
CABERGOLINE |
||||||
P |
8114C |
Tablet 0.5mg |
0.50 |
MG |
31,177 |
2,444,187 |
|
P |
8115D |
Tablet 0.5mg |
0.50 |
MG |
2,032 |
75,156 |
|
G02CB04 |
QUINAGOLIDE |
||||||
P |
8822H |
Tablet 75ug (base) |
75.00 |
UG |
822 |
56,346 |
2010 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($)th> |
GENITO URINARY SYSTEM AND SEX HORMONES |
|||||||
G03AA09 |
DESOGESTREL with ETHINYLOESTRADIOL |
||||||
A |
14249 |
Tablet 28 1 150 ug/30ug |
— |
— |
62,461 |
— |
|
G03AA |
DIENOGEST with ETHINYLOESTRADIOL |
||||||
A |
19955 |
Tablet 2mg-30ug + 7 inert 28 |
— |
— |
1,361 |
— |
|
A |
19956 |
Tablet 2mg-30ug + 7 inert 28x3 |
— |
— |
22,201 |
— |
|
A |
21043 |
Tablet 2mg-30ug + 7 inert 28x3 |
— |
— |
295 |
— |
|
G03AA |
ETHINYLOESTRADIOL and ETONOGESTREL |
||||||
A |
19917 |
Ethinyloest 11.7mg & Etonog 2.7mg vaginal ring 1 |
— |
— |
8,373 |
— |
|
A |
19918 |
Ethinyloest 11.7mg & Etonog 2.7mg vaginal ring 3 |
— |
— |
29,836 |
— |
|
G03AA12 |
ETHINYLOESTRADIOL with DROSPIRENONE |
||||||
A |
17645 |
Tablet 3mg-30ug 21 + 7 inert |
— |
— |
107,323 |
— |
|
A |
17646 |
Tablet 3mg-30ug 21 + 7 inert 28x3 |
— |
— |
512,797 |
— |
|
A |
20451 |
Tablet 3mg-20ug 24+4 |
— |
— |
46,138 |
— |
|
A |
20452 |
Tablet 3mg-20ug 24+4 28x3 |
— |
— |
209,350 |
— |
|
G03AA10 |
ETHINYLOESTRADIOL with GESTODENE |
||||||
A |
15082 |
Tablets 75ug/30ug, 21 + 7 |
— |
— |
8,074 |
— |
|
G03AA07 |
LEVONORGESTREL with ETHINYLOESTRADIOL |
||||||
P |
1393H |
Tablets 150ug-30ug 21 |
— |
— |
6,415 |
111,168 |
|
P |
1394J |
Tablets 150ug-30ug 21 + 7 inert 28 |
— |
— |
1,559,048 |
26,984,653 |
|
P |
1456P |
Tablets 125ug-50ug 21 + 7 inert |
— |
— |
86,259 |
1,494,040 |
|
A |
16212 |
Tablets 100ug-50ug 28 |
— |
— |
126,807 |
— |
|
A |
16217 |
Tablets 100ug-20ug + 7 inert 28 |
— |
— |
17,222 |
— |
|
A |
16970 |
Tablets 100ug-20ug 21 + 7 inert |
— |
— |
124,165 |
— |
|
A |
17708 |
Tablets 100ug 20ug + 7 inert 28x3 |
— |
— |
12,856 |
— |
|
G03AA05 |
NORETHISTERONE with ETHINYLOESTRADIOL |
||||||
P |
2772X |
Tablets 500ug-35ug 21 |
— |
— |
1,117 |
18,703 |
|
P |
2773Y |
Tablets 1mg-35ug, 21 |
— |
— |
878 |
14,550 |
|
P |
2774B |
Tablets 500ug-35ug 21 + 7 inert 28 |
— |
— |
120,026 |
2,008,251 |
|
P |
2775C |
Pack containing 21 tablets 1mg-35ug |
— |
— |
93,249 |
1,560,651 |
|
G03AA05 |
NORETHISTERONE with MESTRANOL |
||||||
P |
3176E |
Tablets 1mg-50ug 21 |
— |
— |
1,943 |
32,527 |
|
P |
3179H |
Tablets 1mg-50ug 21 + 7 inert 28 |
— |
— |
14,126 |
236,468 |
|
G03AA12 |
OESTRADIOL with DROSPIRENONE |
||||||
A |
19550 |
Tablet 1mg-2mg 28 |
— |
— |
38,263 |
— |
|
PROGESTOGENS AND ESTROGENS,SEQUENTIAL PREPARATIONS |
|||||||
G03AB06 |
ETHINYLOESTRADIOL with GESTODENE |
||||||
A |
18555 |
Tablet 30ug/75ug 28x3 |
— |
— |
14,136 |
— |
|
G03AB03 |
LEVONORGESTREL with ETHINYLOESTRADIOL |
||||||
P |
1392G |
Pack containing 6 tablets 50ug |
— |
— |
399,137 |
6,915,815 |
|
G03AB04 |
NORETHISTERONE with ETHINYLOESTRADIOL |
||||||
P |
2776D |
Tablets 500/35ug 12,1000/35ug 9 + 7 inert |
— |
— |
4,561 |
76,435 |
|
PROGESTOGENS |
2010 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
GENITO URINARY SYSTEM AND SEX HORMONES |
|||||||
G03AC08 |
ETONOGESTREL |
||||||
P |
8487Q |
Subcutaneous implant 68mg |
0.07 |
MG |
78,319 |
16,888,041 |
|
G03AC06 |
MEDROXYPROGESTERONE |
||||||
P |
3118D |
Injection 150mg in 1mL |
1.67 |
MG |
230,134 |
3,468,205 |
|
G03AC01 |
NORETHISTERONE |
||||||
P |
1967M |
Tablets 350ug 28 |
— |
— |
32,554 |
543,752 |
|
EMERGENCY CONTRACEPTIVES |
|||||||
G03AD01 |
LEVONORGESTREL |
||||||
A |
19549 |
Tablet 0.75mg 2 |
— |
— |
21,636 |
— |
|
A |
20453 |
Tablet 1.5mg 1 |
— |
— |
2,023 |
— |
|
A |
20617 |
Tablet 1.5mg 1 |
— |
— |
16,224 |
— |
|
A |
21159 |
Tablet 1.5mg 1 |
— |
— |
3,297 |
— |
|
P |
2913H |
Tablets 30ug 28 |
0.03 |
MG |
118,587 |
2,046,987 |
|
ANDROGENS |
|||||||
3-OXOANDROSTEN (4) DERIVATIVES |
|||||||
G03BA03 |
TESTOSTERONE |
||||||
A |
16153 |
Cream 2% 50g |
— |
— |
164 |
— |
|
A |
17178 |
Cream 5% 50g |
— |
— |
152 |
— |
|
P |
2101N |
Injection 250mg |
18.00 |
MG |
46,179 |
1,559,232 |
|
P |
2114G |
Injection 250mg in 1mL |
18.00 |
MG |
12,075 |
406,892 |
|
P |
2115H |
Capsule 40mg |
120.00 |
MG |
30,364 |
1,569,059 |
|
P |
2670M |
Injection 100mg |
18.00 |
MG |
5,270 |
110,349 |
|
P |
8098F |
Subcutaneous implant 100mg |
18.00 |
MG |
2,881 |
546,090 |
|
P |
8099G |
Subcutaneous implant 200mg |
18.00 |
MG |
2,049 |
528,573 |
|
P |
8460G |
Transdermal patch 12.2mg (2.5mg per 24 hr) 60 |
3.00 |
MG |
2,706 |
267,889 |
|
P |
8619P |
Transdermal patch 24.3mg (5mg per 24 hr) 30 |
3.00 |
MG |
7,566 |
766,445 |
|
P |
8830R |
Transdermal gel 50mg in 5mg sachet 30 |
50.00 |
MG |
57,879 |
6,357,460 |
|
P |
9004X |
Injection 1000 mg in 4mL |
18.00 |
MG |
44,649 |
6,587,857 |
|
5-ANDROSTANON (3) DERIVATIVES |
|||||||
G03BB01 |
MESTEROLONE |
||||||
A |
11642 |
Tablet 25mg 50 |
50.00 |
MG |
473 |
— |
|
ESTROGENS |
|||||||
NATURAL AND SEMISYNTHETIC ESTROGENS, PLAIN |
|||||||
G03CA03 |
OESTRADIOL |
||||||
A |
16209 |
Tablet 1mg 28 |
2.00 |
MG |
9,626 |
— |
|
A |
16210 |
Tablet 2mg 28 |
2.00 |
MG |
13,596 |
— |
|
P |
1742Q |
Vaginal tablets 25ug |
0.03 |
MG |
464,585 |
10,793,347 |
|
P |
1743R |
Transdermal patches 2mg 8 |
0.05 |
MG |
61,584 |
1,074,389 |
|
P |
1744T |
Transdermal patches 4mg 8 |
0.05 |
MG |
33,376 |
583,149 |
|
P |
1745W |
Transdermal patches 8mg 8 |
0.05 |
MG |
19,945 |
391,940 |
|
A |
21263 |
Transdermal patches 4mg 8 |
0.05 |
MG |
5,722 |
— |
|
P |
8125P |
Transdermal patches 3.9mg (releasing 50ug/24hrs) |
0.05 |
MG |
41,959 |
730,176 |
|
P |
8126Q |
Transdermal patches 7.8mg (releasing 100ug/24hrs) |
0.05 |
MG |
13,619 |
271,096 |
2010 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
GENITO URINARY SYSTEM AND SEX HORMONES |
|||||||
P |
8140K |
Transdermal patches 1.5mg (releasing 50ug/24hrs) |
0.05 |
MG |
27,044 |
470,250 |
|
P |
8286D |
Transdermal gel 1mg in 1g sachet 28 |
1.00 |
MG |
74,359 |
1,348,002 |
|
P |
8311K |
Transdermal pat 750ug (rel 25ug/24 hrs) |
0.05 |
MG |
14,047 |
244,276 |
|
P |
8312L |
Transdermal patch 3mg (rel 100ug/24 hrs) |
0.05 |
MG |
6,430 |
128,161 |
|
P |
8485N |
Transdermal patches 2mg (releasing 25ug/24hrs) |
0.05 |
MG |
24,585 |
427,609 |
|
P |
8486P |
Transdermal patches 5.7mg (releasing 75ug/24hrs) |
0.05 |
MG |
9,946 |
194,758 |
|
P |
8761D |
Transdermal patches 3.9mg (releasing 25ug/24hrs) |
0.05 |
MG |
18,383 |
319,365 |
|
P |
8762E |
Transdermal patches 5.85mg (releasing 37.5ug/24hrs) |
0.05 |
MG |
26,598 |
462,151 |
|
P |
8763F |
Transdermal patches 7.8mg (releasing 500ug/24hrs) |
0.05 |
MG |
58,828 |
1,023,287 |
|
P |
8764G |
Transdermal patches 1.17mg (releasing 75ug/24hrs) |
0.05 |
MG |
25,055 |
489,990 |
|
P |
8765H |
Transdermal patches 1.56mg (releasing 100ug/24hrs) |
0.05 |
MG |
23,559 |
472,111 |
|
G03CA03 |
OESTRADIOL VALERATE |
||||||
P |
1663M |
Tablets 1mg 28 |
2.00 |
MG |
103,078 |
1,217,207 |
|
P |
1664N |
Tablets 2mg 28 |
2.00 |
MG |
105,643 |
1,512,262 |
|
P |
4365R |
Implant 50mg 1 |
— |
— |
693 |
29,679 |
|
P |
4366T |
Implant 100mg 1 |
— |
— |
3,911 |
430,804 |
|
P |
8274L |
Tablets 2mg 56 |
2.00 |
MG |
11,688 |
162,553 |
|
G03CA04 |
OESTRIOL |
||||||
P |
1771F |
Pessaries 500ug 15 |
0.20 |
MG |
61,818 |
1,312,630 |
|
P |
1781R |
Vaginal cream 1mg per g (0.1%) 15g |
0.20 |
MG |
315,412 |
6,039,393 |
|
A |
19732 |
Tablets 1mg 30 |
2.00 |
MG |
3,042 |
— |
|
G03CA57 |
OESTROGENS CONJUGATED |
||||||
P |
1733F |
Tablets 300ug 28 |
0.63 |
MG |
32,734 |
— |
|
P |
1734G |
Tablets 625ug 28 |
0.63 |
MG |
55,738 |
— |
|
A |
20689 |
Tablets 300ug 28 |
0.63 |
MG |
102,459 |
— |
|
A |
20690 |
Tablets 625ug 28 |
0.63 |
MG |
164,409 |
— |
|
OTHER ESTROGENS |
|||||||
G03CX01 |
TIBOLONE |
||||||
Ap> |
16835 |
Tablet 2.5mg 28 |
2.50 |
MG |
132,286 |
— |
|
A |
20242 |
Tablet 2.5mg 28 |
2.50 |
MG |
141,810 |
— |
|
PROGESTOGENS |
|||||||
PREGNEN (4) DERIVATIVES |
|||||||
G03DA02 |
MEDROXYPROGESTERONE |
||||||
A |
14247 |
Tablet 2.5mg |
5.00 |
MG |
897 |
— |
|
P |
2319C |
Injection 50 mg in 1 mL |
7.00 |
MG |
352 |
4,615 |
|
P |
2321E |
Tablet 10mg |
5.00 |
MG |
33,672 |
553,064 |
|
P |
2323G |
Tablet 5mg 56 |
5.00 |
MG |
83,515 |
1,246,975 |
|
P |
2722G |
Tablet 10mg |
5.00 |
MG |
20,331 |
647,194 |
|
G03DA04 |
PROGESTERONE |
||||||
P |
6366C |
Gel Vaginal (prolonged release) 90mg single dose |
90.00 |
MG |
200 |
— |
|
P |
9609R |
Pessaries 200mg 15 |
90.00 |
MG |
112 |
— |
|
PREGNADIEN DERIVATIVES |
|||||||
G03DB01 |
DYDROGESTERONE |
2010 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
GENITO URINARY SYSTEM AND SEX HORMONES |
|||||||
P |
1350C |
Tablet 10mg |
10.00 |
MG |
10,257 |
179,889 |
|
ESTREN DERIVATIVES |
|||||||
G03DC02 |
NORETHISTERONE |
||||||
P |
2993M |
Tablet 5mg |
5.00 |
MG |
127,866 |
4,900,334 |
|
PROGESTOGENS AND ESTROGENS IN COMBINATION |
|||||||
PROGESTOGENS AND ESTROGENS,FIXED COMBINATIONS |
|||||||
G03FA12 |
MEDROXYPROGESTERONE and ESTROGEN |
||||||
A |
20691 |
Tablet 625ug 2.5mg 28 |
— |
— |
60,372 |
— |
|
A |
20692 |
Tablet 625ug 5mg 28 |
— |
— |
71,855 |
— |
|
P |
8168X |
Tablet 625ug 2.5mg 28 |
— |
— |
20,630 |
— |
|
P |
8169Y |
Tablet 625ug 5mg 28 |
— |
— |
24,858 |
— |
|
G03FA01 |
NORETHISTERONE and ESTROGEN |
||||||
A |
20742 |
Tablets 1mg-500ug, 28 |
— |
— |
92,154 |
— |
|
A |
20743 |
Pack containing 28 tablets 2mg-1mg |
— |
— |
59,095 |
— |
|
P |
8081H |
Pack containing 28 tablets 2mg-1mg |
— |
— |
19,945 |
— |
|
P |
8353P |
Tablets 1mg-500ug, 28 |
— |
— |
31,617 |
— |
|
PROGESTOGENS AND ESTROGENS,SEQUENTIAL PREPARATIONS |
|||||||
G03FB08 |
DYDROGESTERONE and ESTROGEN |
||||||
P |
8244X |
Tabs estradiol 2mg+est/dydro 2mg/10mg,28mg(14/14) |
— |
— |
15,170 |
280,706 |
|
G03FB06 |
MEDROXYPROGESTERONE and ESTROGEN |
||||||
A |
19194 |
Pack 14 tablets oestrogens 625ug |
— |
— |
421 |
— |
|
G03FB05 |
OESTRADIOL with NORETHISTERONE ACETATE |
||||||
P |
1764W |
Tablets sequential pack 2mg-1mg |
— |
— |
14,328 |
— |
|
A |
20741 |
Tablets sequential pack 2mg-1mg |
— |
— |
39,876 |
— |
|
A |
21264 |
Pack containing 4 plain and 4 combo transdermal patches oestradiol |
0.05 |
MG |
265 |
— |
|
P |
8029N |
Pack containing 4 plain and 4 combo transdermal patches oestradiol |
— |
— |
6,461 |
127,265 |
|
P |
8425K |
Transdermal patch 4 4.33mg, 4 620ug/2.7mg |
— |
— |
13,918 |
271,690 |
|
P |
8426L |
Transdermal patch 4 4.33mg, 4 510ug/4.8mg |
— |
— |
8,533 |
168,448 |
|
P |
8427M |
Transdermal patch 620ug/2.7mg, 8 50ug/day |
— |
— |
67,080 |
1,309,011 |
|
P |
8428N |
Transdermal patch 510ug/4.8mg, 8 |
— |
— |
25,107 |
489,499 |
|
GONADOTROPHINS AND OTHER OVULATION STIMULANTS |
|||||||
GONADOTROPHINS |
|||||||
G03GA05 |
FOLLITROPIN ALFA |
||||||
P |
8713N |
Injection 300iu in 0.5mL multi-dose cartridge |
75.00 |
IE |
364 |
226,372 |
|
P |
8714P |
Injection 450iu in 0.75mL multi-dose cartridge |
75.00 |
IE |
454 |
343,794 |
|
P |
8715Q |
Injection 900iu in 1.5mL multi-dose cartridge |
75.00 |
IE |
1,303 |
1,472,961 |
|
G03GA06 |
FOLLITROPIN BETA |
||||||
P |
8565T |
Soln for injection 300iu in 0.36mL mulit-dose cart |
75.00 |
IE |
1,475 |
764,830 |
|
P |
8566W |
Soln for injection 600iu in 0.75mL mulit-dose cart |
75.00 |
IE |
1,901 |
1,360,879 |
|
P |
8871X |
Soln for injection 900iu in 1.08mL mulit-dose cart |
75.00 |
IE |
1,127 |
1,090,925 |
|
G03GA01 |
HUMAN CHORIONIC GONADOTROPHIN |
||||||
P |
1581F |
Ampoules pdr for inj. 1500units and 1mL solvent 3/3 |
250.00 |
IE |
8,267 |
618,445 |
|
P |
6181H |
Powder for inj. 5000units with solvent |
250.00 |
IE |
1,316 |
— |
2010 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
GENITO URINARY SYSTEM AND SEX HORMONES |
|||||||
G03GB02 |
CLOMIPHENE CITRATE |
||||||
P |
1211R |
Tablet 50mg |
9.00 |
MG |
39,750 |
1,433,830 |
|
ANTIANDROGENS |
|||||||
ANTIANDROGENS, PLAIN PREPARATIONS |
|||||||
G03HA01 |
CYPROTERONE ACETATE |
||||||
P |
1269T |
Tablet 50mg |
0.10 |
GM |
20,592 |
1,244,129 |
|
P |
1270W |
Tablet 50mg |
0.10 |
GM |
13,345 |
2,627,308 |
|
P |
8019C |
Tablet 100mg |
0.10 |
GM |
33,754 |
6,618,722 |
|
ANTIANDROGENS AND ESTROGENS |
|||||||
G03HB01 |
CYPROTERONE and ETHINYLOESTRADIOL |
||||||
A |
20836 |
Tablet 35ug/2mg 28 3 |
— |
— |
72,631 |
— |
|
G03HB01 |
CYPROTERONE and OESTROGEN |
||||||
A |
14126 |
Tablet 35ug/2mg 28 1 |
— |
— |
7,979 |
— |
|
A |
14127 |
Tablet 35ug/2mg 28 3 |
— |
— |
54,362 |
— |
|
A |
15418 |
Tablet 35ug/2mg 28 1 |
— |
— |
7,187 |
— |
|
A |
15419 |
Tablet 35ug/2mg28 3 |
— |
— |
143,686 |
— |
|
A |
17090 |
Tablet 35ug/2mg28 1 |
— |
— |
5,644 |
— |
|
A |
17091 |
Tablet 35ug/2mg28 3 |
— |
— |
117,249 |
— |
|
A |
18070 |
Tablet 35ug/2mg 28 1 |
— |
— |
8,970 |
— |
|
A |
18071 |
Tablet 35ug/2mg 28 3 |
— |
— |
137,460 |
— |
|
OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM |
|||||||
ANTIGONADOTROPINS AND SIMILAR AGENTS |
|||||||
G03XA01 |
DANAZOL |
||||||
P |
1285P |
Capsule 100mg |
0.60 |
GM |
746 |
43,676 |
|
P |
1287R |
Capsule 200mg |
0.60 |
GM |
1,420 |
124,612 |
|
G03XA02 |
GESTRINONE |
||||||
P |
8015W |
Capsule 2.5mg |
0.70 |
MG |
167 |
13,665 |
|
ANTIGONADOTROPINS AND SIMILAR AGENTS |
|||||||
G03XC01 |
RALOXIFENE |
||||||
P |
8363E |
Tablet 60mg 28 |
60.00 |
MG |
248,952 |
14,395,900 |
2010 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
GENITO URINARY SYSTEM AND SEX HORMONES |
|||||||
G04BD10 |
DARIFENACIN |
||||||
A |
19785 |
Tablet modified release 7.5 mg (H B r salt) 28 |
7.50 |
MG |
1,875 |
— |
|
A |
19786 |
Tablet modified release 15mg (H B r salt) 28 |
7.50 |
MG |
2,713 |
— |
|
G04BD04 |
OXYBUTYNIN |
||||||
P |
8039D |
Tablet 5mg |
15.00 |
MG |
245,717 |
3,837,203 |
|
P |
9454N |
Transdermal patches 36mg (releasing approx. 3.9mg per 24 hrs) 8, 1 |
3.90 |
MG |
52,303 |
1,887,597 |
|
G04BD08 |
SOLIFENACIN |
||||||
A |
19781 |
Tablet 5mg 30 |
5.00 |
MG |
85,370 |
— |
|
A |
19782 |
Tablet 10mg 30 |
5.00 |
MG |
40,117 |
— |
|
G04BD07 |
TOLTERODINE |
||||||
A |
18891 |
Tablet 1mg 56 |
4.00 |
MG |
1,265 |
— |
|
A |
18892 |
Tablet 2mg 56 |
4.00 |
MG |
7,920 |
— |
|
DRUGS USED IN ERECTILE DYSFUNCTION |
|||||||
G04BE01 |
ALPROSTADIL |
||||||
P |
4579B |
Intracavernosal injection 10ug in single syringe |
0.02 |
MG |
7,218 |
601,234 |
|
P |
4580C |
Intracavernosal injection 20 ug in single syringe |
0.02 |
MG |
17,442 |
1,815,195 |
|
G04BE03 |
SILDENAFIL |
||||||
A |
20993 |
Tablet 100mg 12 |
50.00 |
MG |
2,341 |
— |
|
P |
4584G |
Tablet 25mg 4 |
50.00 |
MG |
2,728 |
456,925 |
|
P |
4585H |
Tablet 50mg 4 |
50.00 |
MG |
41,897 |
3,685,688 |
|
P |
4586J |
Tablet 100mg 4 |
50.00 |
MG |
344,377 |
27,994,268 |
|
P |
9605M |
Tablet 20mg 90 |
50.00 |
MG |
1,926 |
1,812,139 |
|
G04BE08 |
TADALAFIL |
||||||
A |
18863 |
Tablet 20mg 8 |
10.00 |
MG |
60,754 |
— |
|
A |
20367 |
Tablet 5mg 28 |
10.00 |
MG |
19,438 |
— |
|
P |
4596X |
Tablet 10mg 4 |
10.00 |
MG |
17,361 |
1,365,736 |
|
P |
4597Y |
Tablet 20mg 4 |
10.00 |
MG |
240,413 |
19,971,788 |
|
G04BE09 |
VARDENAFIL |
||||||
A |
17961 |
Tablet 10mg 4 |
10.00 |
MG |
2,487 |
— |
|
A |
17963 |
Tablet 20mg 2 |
10.00 |
MG |
43,306 |
— |
|
A |
20239 |
Tablet 20mg 8 |
10.00 |
MG |
8,771 |
— |
|
OTHER UROLOGICALS |
|||||||
G04BX |
SODIUM BICARBONATE |
||||||
A |
20871 |
Capsule 840mg 100 |
— |
— |
628 |
— |
|
P |
9470K |
Capsule 840mg 100 |
— |
— |
33,601 |
472,520 |
|
G04BX |
SODIUM CITRO-TARTRATE |
||||||
P |
4049D |
Sachets cont. oral effervescent powder 4g 28 |
— |
— |
26,514 |
364,658 |
2010 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
GENITO URINARY SYSTEM AND SEX HORMONES |
|||||||
G04CA01 ALFUZOSIN |
|||||||
A |
20995 |
Tablet 10mg 30 |
7.50 |
MG |
1,258 |
— |
|
A |
20996 |
Tablet 10mg 60 |
7.50 |
MG |
284 |
— |
|
G04CA02 |
TAMSULOSIN |
||||||
P |
4070F |
Tablet 400ug (prolonged release) 30 |
0.40 |
MG |
303,780 |
19,253,324 |
|
G04CA03 |
TERAZOSIN |
||||||
P |
4397K |
Tablet 2mg |
5.00 |
MG |
2,167 |
102,537 |
|
P |
4398L |
Tablet 5mg |
5.00 |
MG |
1,785 |
109,491 |
|
P |
4399M |
Tablet 10mg |
5.00 |
MG |
796 |
68,439 |
|
TESTOSTERONE-5-ALPHA REDUCTASE INHIBITORS |
|||||||
G04CB02 |
DUTASTERIDE |
||||||
A |
20722 |
Capsule 500ug 30 |
0.50 |
MG |
11,048 |
— |
|
G04CB01 |
FINASTERIDE |
||||||
A |
16113 |
Tablet 1mg 28 |
— |
— |
64,549 |
— |
|
A |
20715 |
Tablet 5mg 30 |
5.00 |
MG |
3,348 |
— |
|
P |
4233T |
Tablet 5mg |
5.00 |
MG |
57,831 |
6,358,804 |